Circulating levels of sclerostin are associated with cardiovascular mortality.

MLA

Novo-Rodríguez, Cristina, et al. “Circulating Levels of Sclerostin Are Associated with Cardiovascular Mortality.” PLoS ONE, vol. 13, no. 6, June 2018, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0199504.

APA

Novo-Rodríguez, C., García-Fontana, B., Luna-Del Castillo, J. D. D., Andújar-Vera, F., Ávila-Rubio, V., García-Fontana, C., Morales-Santana, S., Rozas-Moreno, P., & Muñoz-Torres, M. (2018). Circulating levels of sclerostin are associated with cardiovascular mortality. PLoS ONE, 13(6), 1–14. https://doi.org/10.1371/journal.pone.0199504

Chicago

Novo-Rodríguez, Cristina, Beatriz García-Fontana, Juan De Dios Luna-Del Castillo, Francisco Andújar-Vera, Verónica Ávila-Rubio, Cristina García-Fontana, Sonia Morales-Santana, Pedro Rozas-Moreno, and Manuel Muñoz-Torres. 2018. “Circulating Levels of Sclerostin Are Associated with Cardiovascular Mortality.” PLoS ONE 13 (6): 1–14. doi:10.1371/journal.pone.0199504.